Diligence memo · auto-generated · as of July 3, 2026

Logan Surgical Suites, LLC

Logan Surgical Suites, LLC looks fair against its niche peers and is quiet on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Logan Surgical Suites, LLC operates in Medical Devices, based in LOGAN.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Logan Surgical Suites, LLC has raised $1.1M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $545K on 2022-11-28.

Most recent recorded round closed around 2024-01-23.

Valuation (modeled)modeled

Provath models Logan Surgical Suites, LLC at approximately $2.8M (range $306K–$11M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.00× the median modeled value of Pre-Seed Medical Devices companies in 2022–2024 (29 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 14 months.

Last raise 2.4 yr ago; this sector typically re-raises about every 16 months.

Slightly overdue versus sector cadence.

The last round was 1.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 43% of Medical Devices peers (233 compared).

Modeled value ranks above 29% of those peers.

Closest niche peers: Turbett Surgical, Inc., Owensboro Ambulatory Surgical Facility Ltd, Seashore Surgical Institute, L.L.C., Hera Diagnostics Corp, Hawkeye Surgical Lighting.

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.